AVTE   $2.38  2.59% Market Closed After Close 2.37 -0.42%

Aerovate Therapeutics Inc
Total Cash 104.20M
totalCashPerShare 3.61
EBITDA -94.11M
Total Debt 681.00K
quickRatio 6.122
currentRatio 6.508
Total Revenue
debtToEquity 0.721
Revenue/Share
ROA -0.44035
ROE -0.74421
grossProfits
freeCashflow -44.86M
operatingCashflow -74.52M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -42.61M
forwardPE -2.36
floatShares 11.85M
sharesOutstanding 28.87M
sharesShort 846.45K
sharesShortPriorMonth 1.27M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.00%
Short Ratio help_outline 3.83%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 3.271
Price To Book help_outline 0.72
earningsQuarterlyGrowth
netIncomeToCommon -87.94M
trailingEps -3.13%
forwardEps -1.00%
enterpriseToEbitda 0.45
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.58 3Q 2024
institutionsCount 116
lastUpdated Oct. 17, 2024, 12:05 a.m.